|

Gemcitabine alone Clinical Trials

2 actively recruiting trials

Also known as: Gemzar

Pipeline

Phase 3: 2

Top Sponsors

  • Maia Biotechnology1
  • Intergroupe Francophone de Cancerologie Thoracique1

Indications

  • Lung Cancer2
  • Cancer2
  • MET Exon 14 Mutation1
  • Advanced Non-Small Cell Lung Cancer1
  • Carcinoma, Non-Small-Cell Lung1

Other2 trials

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Phase 3
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.